Debate Over Pricey Drug Developed At UCLA Offers Snapshot Of Nationwide Issue
Advocacy groups insist that consumers will be hurt if the university issues a patent on the cancer drug.
Battle Over A Pricey Drug Now Engulfs The University Of California
Dozens of advocacy groups are urging one of the largest American universities not to pursue a patent for a pricey cancer drug in India, opening another front in an ongoing battle over access to the medicine. At issue is the Xtandi prostate cancer treatment, which was originally invented at the University of California, Los Angeles, and has become a flashpoint in a wider debate in the United States over the extent to which Americans should pay high prices for medicines that were developed, at least in part, with taxpayer dollars. (Silverman, 5/25)